4//SEC Filing
BFI Co., LLC 4
Accession 0001144204-18-038033
CIK 0001069899other
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 8:11 PM ET
Size
12.8 KB
Accession
0001144204-18-038033
Insider Transaction Report
Form 4
BFI Co., LLC
10% Owner
Transactions
- Conversion
Class A Common Stock
2018-07-09+30,000→ 60,000 total - Sale
Class A Common Stock
2018-07-10$46.81/sh−10,000$468,100→ 40,000 total - Sale
Class A Common Stock
2018-07-11$46.89/sh−10,000$468,900→ 30,000 total - Sale
Class A Common Stock
2018-07-09$46.96/sh−10,000$469,600→ 50,000 total - Conversion
Class B Common Stock
2018-07-09−30,000→ 20,335,504 totalExercise: $0.00→ Class A Common Stock (30,000 underlying)
Footnotes (5)
- [F1]Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.70 to $47.35, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.45 to $47.25, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.45 to $47.20, inclusive.
Documents
Issuer
PHIBRO ANIMAL HEALTH CORP
CIK 0001069899
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001601607
Filing Metadata
- Form type
- 4
- Filed
- Jul 10, 8:00 PM ET
- Accepted
- Jul 11, 8:11 PM ET
- Size
- 12.8 KB